<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068308/" ref="ordinalpos=2014&amp;ncbi_uid=2899237&amp;link_uid=PMC3068308" image-link="/pmc/articles/PMC3068308/figure/fig5/" class="imagepopup">Figure 5.  From: Molecular Characteristics of Pancreatic Ductal Adenocarcinoma. </a></div><br /><div class="p4l_captionBody">The TGF-β signaling pathway. The TGF-β signaling pathway is activated by binding of TGF-β to a type II receptor, which facilitates the recruitment and phosphorylation of the type I receptor. This pTGF-βRI activates either SMAD2 or SMAD3 by phosphorylation. The phosphorylated SMAD2/3 forms a complex with SMAD4 and transports to the nucleus where it influences SMAD target gene transcription. SMAD7 can inhibit TGF-β signaling through inhibition of TGF-βRI phosphorylation.</div></div>